KFP
WST icon

KB Financial Partners’s West Pharmaceutical WST Stock Holding History

KB Financial Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$61K Sell
162
-42
-21% -$16.2K 0.02% 236
2023
Q2 		$78K Buy
204
+7
+4% +$2.5K 0.02% 226
2023
Q1 		$68K Hold
197
– – 0.02% 234
2022
Q4 		$46K Sell
197
-8
-4% -$1.9K 0.02% 270
2022
Q3 		$50K Hold
205
– – 0.02% 245
2022
Q2 		$62K Sell
205
-17
-8% -$5.53K 0.02% 236
2022
Q1 		$91K Hold
222
– – 0.03% 227
2021
Q4 		$104K Buy
+222
New +$95.6K 0.03% 231
2021
Q3 		– Sell
-226
Closed -$81K – 569
2021
Q2 		$81K Sell
226
-150
-40% -$49.6K 0.03% 222
2021
Q1 		$106K Buy
+376
New +$108K 0.05% 200

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

KB Financial Partners's WST Position: Q3 2023 in Review

KB Financial Partners reduced its West Pharmaceutical (WST) stake by 21% in Q3 2023, selling an estimated $16.2K and leaving 162 shares worth $61K. The position accounts for 0.02% of the portfolio, ranked #236.

KB Financial Partners first reported a position in WST in Q1 2021 and has held it in 10 quarters since. The position peaked at $106K in Q1 2021. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • KB Financial Partners held 162 shares of West Pharmaceutical worth $61K as of Q3 2023.
  • KB Financial Partners sold 42 West Pharmaceutical shares in Q3 2023, an estimated $16.2K.
  • West Pharmaceutical made up 0.02% of KB Financial Partners's portfolio in Q3 2023, its #236 holding.
  • KB Financial Partners first reported a position in West Pharmaceutical in Q1 2021 and has held it in 10 quarters since.
  • KB Financial Partners's West Pharmaceutical position peaked at $106K in Q1 2021.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.